Nicotinamide Deficiency in Primary Open-Angle Glaucoma
Open Access
- 3 June 2019
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 60 (7) , 2509-2514
Abstract
Purpose: To investigate the plasma concentration of nicotinamide in primary open-angle glaucoma (POAG). Methods: Plasma of 34 POAG individuals was compared to that of 30 age- and sex-matched controls using a semiquantitative method based on liquid chromatography coupled to high-resolution mass spectrometry. Subsequently, an independent quantitative method, based on liquid chromatography coupled to mass spectrometry, was used to assess nicotinamide concentration in the plasma from the same initial cohort and from a replicative cohort of 20 POAG individuals and 15 controls. Results: Using the semiquantitative method, the plasma nicotinamide concentration was significantly lower in the initial cohort of POAG individuals compared to controls and further confirmed in the same cohort, using the targeted quantitative method, with mean concentrations of 0.14 μM (median: 0.12 μM; range, 0.06–0.28 μM) in the POAG group (−30%; P = 0.022) and 0.19 μM (median: 0.18 μM; range, 0.08–0.47 μM) in the control group. The quantitative dosage also disclosed a significantly lower plasma nicotinamide concentration (−33%; P = 0.011) in the replicative cohort with mean concentrations of 0.14 μM (median: 0.14 μM; range, 0.09–0.25 μM) in the POAG group, and 0.19 μM (median: 0.21 μM; range, 0.09–0.26 μM) in the control group. Conclusions: Glaucoma is associated with lower plasmatic nicotinamide levels, compared to controls, suggesting that nicotinamide supplementation might become a future therapeutic strategy. Further studies are needed, in larger cohorts, to confirm these preliminary findings.Keywords
All Related Versions
This publication has 26 references indexed in Scilit:
- The Effect of Vitamins on Glaucoma: A Systematic Review and Meta-AnalysisNutrients, 2018
- Glaucoma as a Metabolic Optic Neuropathy: Making the Case for Nicotinamide Treatment in GlaucomaJournal of Glaucoma, 2017
- GlaucomaThe Lancet, 2017
- Nicking Glaucoma with Nicotinamide?New England Journal of Medicine, 2017
- Vitamin B 3 modulates mitochondrial vulnerability and prevents glaucoma in aged miceScience, 2017
- A Nontargeted UHPLC-HRMS Metabolomics Pipeline for Metabolite Identification: Application to Cardiac Remote Ischemic PreconditioningAnalytical Chemistry, 2017
- Glaucoma: Focus on mitochondria in relation to pathogenesis and neuroprotectionEuropean Journal of Pharmacology, 2016
- Measurement of Systemic Mitochondrial Function in Advanced Primary Open-Angle Glaucoma and Leber Hereditary Optic NeuropathyPLOS ONE, 2015
- Metabolome-Wide Association Study of Primary Open Angle GlaucomaInvestigative Ophthalmology & Visual Science, 2015
- Impaired Complex-I-Linked Respiration and ATP Synthesis in Primary Open-Angle Glaucoma Patient LymphoblastsInvestigative Ophthalmology & Visual Science, 2012